Industry Insights
2025 Leadership Report
For more than four decades, Business Executives for National Security (BENS) has served as a trusted bridge between business leaders and the national security community—bringing private sector expertise to help…
America’s National Security Vulnerability: Generic Drug Manufacturing and Biotechnology Innovation
BENS Assessment that outlines policy recommendations to strengthen U.S. pharmaceutical supply chains
The National Security Private Investment Scorecard
A Practitioner Recommendation for Mobilizing Private Capital by Wayne Sanders
Defense Contractor Stability Pool: Converting Termination Risk into Insurable Protection
A Practitioner Recommendation for Mobilizing Private Capital by Andrew Hersh
The DIB Transition Accelerator: De-Risking M&A to Lower the Cost of Capital for Small Defense Businesses
A Practitioner Recommendation for Mobilizing Private Capital by Michael Dworkis
Operation Arsenal Speed: Open Defense Production to Commercial Manufacturers
A Practitioner Recommendation for Mobilizing Private Capital by Stan Crow
Countering Influence, Securing Opportunity: A Private Sector View from Argentina
Analysis and 10 recommendations following a BENS delegation visit to Buenos Aires, where they examine how a stronger U.S.-Argentina partnership can counter growing Chinese influence
Arsenal of Democracy 2.0: Mobilizing Modern Capital for America’s Defense
By General Timothy M. Ray, USAF (Ret.) & Al Puchala
How to Fix Argentina’s Currency Crisis
By BENS President & CEO Gen. Tim Ray (Ret.) and BENS Vice Chair Ramon Marks, published in The National Interest. All rights reserved. The United States must do more than…
Pharmaceutical Blackout: The Hidden Threat to U.S. Security
By BENS Member Stuart Glickman and BENS President & CEO Gen. Tim Ray (Ret.), published in RealClearDefense.